Stock Chart
ASND
Type: SELL growth_1yr
Strike: $220
Premium: $41.15
Expiry: Dec 18, 2026
Target: $203
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About ASND - Ascendis Pharma A/S American Depositary Shares
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
Key Statistics
More ASND Analysis
This ASND stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ASND's price movements with trendlines, gamma walls, and key support/resistance levels.